Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- KRUS +2%
Other news:
- VRNA +20.7% (Verona Pharma to be acquired by Marck (MRK) for $107 per ADS)
- AES +14.1% (explores options, including possible sale, amid takeover interest from large investment firms, according to Bloomberg)
- RYTM +7.2% (to announce topline results from Phase 2 Trial for Oral MC4R)
- NSPR +4% (launches CGuard Prime Carotid Stent System in the US)
- TIXT +2.6% (provided an update on its process in respect of the previously announced unsolicited non-binding proposal received from TELUS Corporation)
- ALVO +2.2% (acquires Ivers-Lee Group in Switzerland)
- SLDB +2.1% (FDA approves IND and Health Canada approves CTA for SGT-501)
- PLUG +2.1% (extends strategic hydrogen supply agreement with multi-year contract)
- SBUX +1.5% (has received proposals for its China business, according to Bloomberg)